专利检索 ap:("Clarus Therapeutics, Inc.") AND inv:"CONSTANTINIDES, Panayiotis, P." 第 1 页

1.

发明授权
ORAL TESTOSTERONE ESTER FORMULATIONS AND METHODS OF TREATING TESTOSTERONE DEFICIENCY COMPRISING SAME 有权
标题翻译：口服睾酮酯制剂和方法睾酮缺乏，以便在处理

公开(公告)号：EP2558073B1

公开(公告)日：2014-09-10

申请号：EP10714521.1

申请日：2010-04-12

申请人： Clarus Therapeutics, Inc.

发明人： DUDLEY, Robert, E. , CONSTANTINIDES, Panayiotis, P.

IPC分类号： A61K9/107 , A61K9/48 , A61K31/568 , A61K47/12 , A61K47/14 , A61K47/44

CPC分类号： A61K9/1075 , A61K9/4858 , A61K31/568 , A61K47/12 , A61K47/44

2.

发明公开
PHARMACEUTICAL DELIVERY SYSTEMS FOR HYDROPHOBIC DRUGS AND COMPOSITIONS COMPRISING SAME 审中-公开
标题翻译：系统对疏水性和组成的营销管理THEREFORE

公开(公告)号：EP1871384A2

公开(公告)日：2008-01-02

申请号：EP06758358.3

申请日：2006-04-14

申请人： Clarus Therapeutics, Inc.

发明人： DUDLEY, Robert, E. , CONSTANTINIDES, Panayiotis, P.

IPC分类号： A61K31/573

CPC分类号： A61K31/568 , A61K9/0053 , A61K9/06 , A61K9/1075 , A61K9/4858 , A61K31/22 , A61K31/573 , A61K47/10 , A61K47/12 , A61K47/14 , A61K47/26 , A61K47/44 , C07J1/00 , A61K2300/00

摘要： A drug delivery system for oral administration of hydrophobic drugs with enhanced and extended absorption and improved pharmacokinetics is provided. In one embodiment, formulations comprising testosterone and testosterone esters are disclosed. Method of treating a hormone deficiency or effecting male contraception with the formulations are also provided.

3.

发明公开
ORAL TESTOSTERONE ESTER FORMULATIONS AND METHODS OF TREATING TESTOTERONE DEFICIENCY COMPRISING SAME 有权
标题翻译：口服睾酮酯制剂和方法睾酮缺乏，以便在处理

公开(公告)号：EP2558073A1

公开(公告)日：2013-02-20

申请号：EP10714521.1

申请日：2010-04-12

申请人： Clarus Therapeutics, Inc.

发明人： DUDLEY, Robert, E. , CONSTANTINIDES, Panayiotis, P.

IPC分类号： A61K9/107 , A61K9/48 , A61K31/568 , A61K47/12 , A61K47/14 , A61K47/44

CPC分类号： A61K9/1075 , A61K9/4858 , A61K31/568 , A61K47/12 , A61K47/44

摘要： A pharmaceutical formulation of testosterone undecanoate is provided. Methods of treating a testosterone deficiency or its symptoms with the inventive formulations are also provided.